2. Efficacy and safety of a new botulinum toxin (HU-014) versus existing onabotulinumtoxin A in subjects with moderate to severe glabellar lines. Dermatologic Surgery (2021)
3. Phase I/III clinical trial to evaluate the safety and efficacy of a new botulinum toxin (HU-014) versus OnabotulinumtoxinA in subjects with moderate-to-severe crow's feet lines. Dermatologic Surgery (2021)
7. A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox® versus Botox® in Post-Stroke Upper Limb Spasticity. Toxins (2023)
8. Is There a Correlation Between Masticatory Muscle Thickness and Pain After Botulinum Toxin Injections in Myogenic TMD Patients?: A Pilot Study. Toxins (2025)